TrialJournal of translational medicine2014

Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts.

Sergio Rutella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.